Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Carcinoma of Unknown Primary; Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Nasopharyngeal Squamous Cell Carcinoma; Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Tolinapant; Radiation: Radiation Therapy Sponsors: Emory University; Astex Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Carcinoma of Unknown Primary; Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Nasopharyngeal Squamous Cell Carcinoma; Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Tolinapant; Radiation: Radiation Therapy Sponsors: Emory University; Astex Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Carcinoma of Unknown Primary; Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Nasopharyngeal Squamous Cell Carcinoma; Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Tolinapant; Radiation: Radiation Therapy Sponsors: Emory University; Astex Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials
An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma
Conditions: Larynx Cancer; Larynx Carcinoma Intervention: Other: Obtaining blood samples Sponsor: Hacettepe University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2022 Category: Research Source Type: clinical trials